Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow

Blood

Volumn 104, Issue 10, 2004, Pages 3221-3227

  Mazzucato, Mario ^c   Cozzi, Maria Rita ^c   Pradella, Paola ^c   Ruggeri, Zaverio M ^b   De Marco, Luigi ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; APYRASE; ARC 69931MX; CALCIUM; MRS 2216; PHOSPHOLIPASE C; PROSTAGLANDIN E1; PROTEIN TYROSINE KINASE; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; WORTMANNIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CYTOPLASM; DRUG INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 8644278154     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1145     Document Type: Article

References (43)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234.
2. Ware J. Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost. 1998;79:466-478.
3. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289-297.
4. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657-666.
5. Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 1999;94:172-178.
6. Kato K, Kanaji T, Russell S, et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102:1701-1707.
7. 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J Biol Chem. 2002;277:2965-2972.
8. Mazzucato M, Pradella P, Cozzi MR, De Marco L, Ruggeri ZM. Sequential cytoplasmic calcium signals in a two-stage platelet activation process induced by the glycoprotein Ibα mechanoreceptor. Blood. 2002;100:2793-2800.
9. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 1988;71:1366-1374.
10. Hollopeter G, Jantzen H-M, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001;409:202-206.
11. 1-deficient mice. Nat Med. 1999;5:1199-1202.
12. Gachet C. ADP receptors of platelets and their inhibitors. Thromb Haemost. 2001;86:222-232.
13. Woulfe D, Yang J, Brass L. ADP and platelets: the end of the beginning. J Clin Invest. 2001;107:1503-1505.
14. 1 is required to inhibit platelet aggregation in whole blood under flow. Blood. 2001;98:3340-3345.
15. 2-. Biochem J. 1990;269:513-519.
16. De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM. Interaction of purified IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. Proc Natl Acad Sci U S A. 1985;82:7424-7428.
17. Usami S, Chen HH, Zhao Y, Chien S, Skalak R. Design and construction of a linear shear stress flow chamber. Ann Biomed Eng. 1993;21:77-83.
18. Kim HS, Barak D, Harden TK, Boyer JL, Jacobson KA. Acyclic and cyclopropyl analogues of adenisine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking. J Med Chem. 2001;44:3092-3108.
19. Ingall HL, Dixon J, Bailey A, et al. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem. 1999;42:213-220.
20. Remijn JA, Wu YP, Jeninga EH, et al. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterloscler Thromb Vasc Biol. 2002;22:686-691.
21. Niiya K, Hodson E, Bader R, et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation: relationship to the binding of fibrinogen and platelet aggregation. Blood. 1987;70:475-483.
22. Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Natl Acad Sci U S A. 1963;113:989-994.
23. Martinez J, Holburn RR, Shapiro SS, Erslev AJ. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. J Clin Invest. 1974;53:600-611.
24. Mazzucato M, Spessotto P, Masotti A, et al. Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow. J Biol Chem. 1999;274:3033-3041.
25. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994;269:5241-5248.
26. 3: studies in human platelets and transfected Chinese hamster ovary cells. J Biol Chem. 2000;275:41377-41388.
27. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol. 1999;276:C267-C278.
28. Weiss HJ, Witte LD, Kaplan KL, et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood. 1979;54:1296-1319.
29. Lockhart LK, McNicol A. The phospnolipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. J Pharmacol Exp Ther. 1999;289:721-728.
30. Mangin P, Yuan Y, Goncalves I, et al. Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization: involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. J Biol Chem. 2003;278:32880-32891.
31. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11-21.
32. Kasirer-Friede A, Cozzi MR, Mazzucato M, et al. Signaling through GP Ib-IX-V activates αIIbβ3 independently of other receptors. Blood. 2004;103:2003-2010.
33. Marshall SJ, Senis YA, Auger JM, et al. GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase. Blood. 2004;103:2601-2609.
34. Falati S, Edmead CE, Poole AW. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets. Blood. 1999;94:1648-1656.
35. 12) in platelet activation inititated by binding of von Willebrand factor to platelet Gp Ibα induced by conditions of high shear rate. Circulation. 2002;105:2531-2536.
36. Savage B, Sixma JJ, Ruggeri ZM. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci U S A. 2002;99:425-430.
37. Nesbitt WS, Giuliano S, Kulkarni S, et al. Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol. 2003;160:1151-1161.
38. 3. Blood. 2002;99:151-158.
39. Kovacsovics TJ, Bachelot C, Toker A, et al. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem. 1995;270:11358-11366.
40. Ding J, Vlahos CJ, Liu R, Brown RF, Badwey JA. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J Biol Chem. 1995;270:11684-11691.
41. Powis G, Bonjouklian R, Berggren MM, et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994;54:2419-2423.
42. Lizcano JM, Alrubaie S, Kieloch A, et al. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. Biochem J. 2003;374:297-306.
43. c-src in human platelets. J Biol Chem. 1994;268:27093-27099.